YILMAZ ORAL, D. Et Al. 2020. Evaluation of combined therapeutic effects of hydrogen sulfide donor sodium hydrogen sulfide and phosphodiesterase type-5 inhibitor tadalafil on erectile dysfunction in a partially bladder outlet obstructed rat model. NEUROUROLOGY AND URODYNAMICS , vol.39, no.4 , 1087-1097.

YILMAZ ORAL, D., KAYA SEZGİNER, E., Oztekin, C. V., Bayatli, N., LOKMAN, U., & GÜR, S., (2020). Evaluation of combined therapeutic effects of hydrogen sulfide donor sodium hydrogen sulfide and phosphodiesterase type-5 inhibitor tadalafil on erectile dysfunction in a partially bladder outlet obstructed rat model. NEUROUROLOGY AND URODYNAMICS , vol.39, no.4, 1087-1097.

YILMAZ ORAL, DİDEM Et Al. "Evaluation of combined therapeutic effects of hydrogen sulfide donor sodium hydrogen sulfide and phosphodiesterase type-5 inhibitor tadalafil on erectile dysfunction in a partially bladder outlet obstructed rat model," NEUROUROLOGY AND URODYNAMICS , vol.39, no.4, 1087-1097, 2020

YILMAZ ORAL, DİDEM Y. Et Al. "Evaluation of combined therapeutic effects of hydrogen sulfide donor sodium hydrogen sulfide and phosphodiesterase type-5 inhibitor tadalafil on erectile dysfunction in a partially bladder outlet obstructed rat model." NEUROUROLOGY AND URODYNAMICS , vol.39, no.4, pp.1087-1097, 2020

YILMAZ ORAL, D. Et Al. (2020) . "Evaluation of combined therapeutic effects of hydrogen sulfide donor sodium hydrogen sulfide and phosphodiesterase type-5 inhibitor tadalafil on erectile dysfunction in a partially bladder outlet obstructed rat model." NEUROUROLOGY AND URODYNAMICS , vol.39, no.4, pp.1087-1097.

@article{article, author={DİDEM YILMAZ ORAL Et Al. }, title={Evaluation of combined therapeutic effects of hydrogen sulfide donor sodium hydrogen sulfide and phosphodiesterase type-5 inhibitor tadalafil on erectile dysfunction in a partially bladder outlet obstructed rat model}, journal={NEUROUROLOGY AND URODYNAMICS}, year=2020, pages={1087-1097} }